Skip to content

Study · Not a test of the peptide alone · 2013

1 result

Short cell-penetrating peptides: a model of interactions with gene promoter sites.

Khavinson VKh, Tarnovskaya SI, Linkova NS, Pronyaeva VE, Shataeva LK, Yakutseni PP

Bulletin of experimental biology and medicine1 Jan 2013Cited by 13 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Epitalon.

  1. 01Computer modelNot a test of Epitalon aloneIn silicoMechanism

    A molecular model of Lys-Glu and Ala-Glu-Asp-Gly (AEDG) interactions with DNA sites GCAG and ATTTC in gene promoters was built.

    In plain wordsA computer model predicted how the peptide AEDG and one other peptide could interact with DNA sites in gene control regions.

    Peptide
    Epitalon
    Outcome
    Not applicableModelled AEDG interaction with promoter DNA sites
    Study

    n: not reported in source

    molecular mechanics model of peptide-DNA complexes
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Based on these estimations, a three-dimensional model of Lys-Glu and Ala-Glu-Asp-Gly peptide interactions with DNA sites (GCAG and ATTTC) located in the promoter zones of genes encoding CD5, IL-2, MMP2, and Tram1 signal molecules.
    1 context sentence
    Summary · context
    Analysis of the main parameters of molecular mechanics (number of hydrogen bonds, hydrophobic and electrostatic interactions, DNA-peptide complex minimization energy) provided the data to validate the previously proposed qualitative models of peptide-DNA interactions and to evaluate their quantitative characteristics.

    In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Epitalon.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 08:19 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.